Source: Eur Respir J, 51 (4) 1702519; 10.1183/13993003.02519-2017
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ivo A. Wiertz, Coline H.M. van Moorsel, Adriane D.M. Vorselaars, Marian J.R. Quanjel, Jan C. Grutters. Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF). Eur Respir J, 51 (4) 1702519; 10.1183/13993003.02519-2017

Member's Comments

No comment yet.

Related content which might interest you: Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005 Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Non-IPF idiopathic interstitial pneumonia (IIPs) Source: ERS Course 2016 Year: 2016 Non-IPF idiopathic interstitial pneumonias Source: School Course 2014 - Interstitial lung diseases Year: 2014 Interstitial pneumonia with autoimmune features Source: Eur Respir Monogr 2019; 86: 140-152 Year: 2019 Interstitial pneumonia with autoimmune features Source: Guideline 2015 Year: 2015 Idiopathic non-specific interstitial pneumonia (NSIP): is it an autoimmune clinical entity? Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Clinical-radiographic-pathologic diagnosis in idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia Source: Eur Respir J 2002; 19: 1114-1118 Year: 2002 Characterisation of patients with interstitial pneumonia with autoimmune features Source: Eur Respir J 2016; 47:1767-1775 Year: 2016 Nonspecific interstitial pneumonia - NSIP Source: Respipedia Article Year: 2015 The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias Source: Eur Respir Rev 2008; 17: 108-115 Year: 2008 Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia. Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Clinical significance of histological classification of idiopathic interstitial pneumonia Source: Eur Respir J 2002; 19: 275-283 Year: 2002 Fibrosing alveolitis in rheumatoid arthritis (FARA):a survival comparison with idiopathic usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP) Source: Eur Respir J 2003; 22: Suppl. 45, 197s Year: 2003 Impact of comorbidities in interstitial pneumonia with autoimmune features (IPAF) Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: 43S-55S Year: 2001 Prevalence and clinical characteristics of unclassifiable idiopathic interstitial pneumonias (IIPs) Source: International Congress 2017 – Novel and old entities Year: 2017 Clinical categorisation of idiopathic interstitial pneumonia Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management Year: 2005 Clinico-radiological-pathological features of MPO-ANCA-positive interstitial pneumonia Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007